• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Australia's National Health and Medical Research Council to streamline trials

Australia's National Health and Medical Research Council to streamline trials

August 5, 2015
CenterWatch Staff

As part of an initiative to have quicker and more efficient research governance authorization, Australia’s National Health and Medical Research Council (NHMRC) has developed the Good Practice Process for Site Assessment and Authorization Phases of Clinical Trial Research Governance.

The Good Practice Process was developed and finalized following extensive stakeholder consultation by the NHMRC’s Research Governance Working Group. This group has broad representation from clinical trials sites, clinical trial sponsors and state/territory health departments.

The Good Practice Process aims to streamline the site assessment and site authorization of clinical trials by:

  • Outlining a set of principles and critical success factors for site assessment and site authorization;
  • Detailing a set of planning and preparation activities that can made a site more responsive to commencing clinical trials; and
  • Proposing a streamlined workflow for site assessment and authorization. 

NHMRC is piloting the Good Practice Process in 16 clinical trial sites across seven states and territories. 

Once details on the effectiveness of the Good Practice Process have been collected, and any modifications made, it is expected that the Good Practice Process will be implemented at all clinical trials sites to facilitate a standardized approach to clinical trials research governance.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing